Faculty of Medicine & Health, School of Dentistry, University of Leeds, Leeds, UK.
Faculty of Medicine & Health, School of Healthcare, University of Leeds, Leeds, UK.
Eur J Pain. 2019 May;23(5):849-865. doi: 10.1002/ejp.1358. Epub 2019 Feb 7.
Psychosocial risk factors associated with chronic orofacial pain are amenable to self-management. However, current management involves invasive therapies which lack an evidence base and has the potential to cause iatrogenic harm.
To determine: (a) whether self-management is more effective than usual care in improving pain intensity and psychosocial well-being and (b) optimal components of self-management interventions.
Cochrane Oral Health Group Trials Register, Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, PsycINFO, WHO International Clinical Trials Registry Platform and Clinical Trials.gov were searched. Meta-analysis was used to determine effectiveness, and GRADE was used to rate quality, certainty and applicability of evidence.
Fourteen trials were included. Meta-analyses showed self-management was effective for long-term pain intensity (standardized mean difference [SMD] -0.32, 95% confidence interval [CI] -0.47 to -0.17) and depression (SMD -0.32, 95% CI -0.50 to -0.15). GRADE analysis showed a high score for certainty of evidence for these outcomes and significant effects for additional outcomes of activity interference (-0.29 95% CI -0.47 to -0.11) and muscle palpation pain (SMD -0.58 95% CI -0.92 to -0.24). Meta-regression showed nonsignificant effects for biofeedback on long-term pain (-0.16, 95% CI -0.48 to 0.17, p-value = 0.360) and depression (-0.13, 95% CI -0.50 to 0.23, p-value = 0.475).
Self-management interventions are effective for patients with chronic orofacial pain. Packages of physical and psychosocial self-regulation and education appear beneficial. Early self-management of chronic orofacial pain should be a priority for future testing.
This systematic review provides clear evidence for effectiveness of combined biomedical and psychological interventions (incorporating self-management approaches) on long-term outcomes in the management of chronic orofacial (principally TMD) pain. Self-management should be a priority for early intervention in primary care in preference to invasive, irreversible and costly therapies. Further research is needed firstly to clarify the relative effectiveness of specific components of self-management, both individually and in conjunction, and secondly on outcomes in other types of chronic orofacial pains.
与慢性口面痛相关的心理社会风险因素可通过自我管理来改善。然而,目前的治疗方法包括侵入性治疗,缺乏循证医学依据,并有造成医源性损伤的潜在风险。
确定:(a)自我管理是否比常规护理更能有效改善疼痛强度和心理社会幸福感,以及(b)自我管理干预的最佳组成部分。
Cochrane 口腔健康组试验注册库、Cochrane 对照试验中心注册库、MEDLINE、EMBASE、PsycINFO、世界卫生组织国际临床试验注册平台和 ClinicalTrials.gov 进行了检索。采用荟萃分析确定疗效,并用 GRADE 评估证据的质量、确定性和适用性。
纳入了 14 项试验。荟萃分析显示,自我管理对长期疼痛强度(标准化均数差 [SMD] -0.32,95%置信区间 [CI] -0.47 至 -0.17)和抑郁(SMD -0.32,95%CI -0.50 至 -0.15)均有效。GRADE 分析显示,这些结局的证据确定性评分较高,且对活动干扰(SMD -0.29,95%CI -0.47 至 -0.11)和肌肉触压痛(SMD -0.58,95%CI -0.92 至 -0.24)等其他结局的效果显著。元回归显示生物反馈对长期疼痛(SMD -0.16,95%CI -0.48 至 0.17,p 值=0.360)和抑郁(SMD -0.13,95%CI -0.50 至 0.23,p 值=0.475)的影响无统计学意义。
自我管理干预对慢性口面痛患者有效。物理和心理社会自我调节与教育相结合的方案似乎有益。早期对慢性口面痛进行自我管理应成为未来研究的重点。
本系统评价提供了明确的证据,证明了综合生物医学和心理干预(包括自我管理方法)对慢性口面痛(主要为 TMD)疼痛的长期结局具有疗效。自我管理应该成为初级保健中早期干预的首选,而不是采用侵入性、不可逆和昂贵的治疗方法。进一步的研究首先需要阐明自我管理的特定组成部分的相对有效性,包括单独和联合使用,其次是其他类型的慢性口面痛的结局。